This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on June 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
RFQ Human Cytokine/Chemokine/Growth Factor Panel A
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institute of Mental Health, through the Office of Logistics and Acquisition Operations of the Department of Health and Human Services, has issued a competitive combined synopsis/solicitation for commercial items under FAR 12.603 to procure specialized biological laboratory supplies for research into biomarkers associated with mood disorders and the effects of novel antidepressants. The solicitation, numbered 75N98026Q00516 and posted on June 4, 2026, with a response deadline of June 18, 2026 at 5:30 p.m. EDT, seeks four Human Cytokine/Chemokine/Growth Factor Panel A 48 Plex Immunoassay Kits, one MAGPIX Performance Verification Kit (MPXPVER-K25), and one MAGPIX Calibration Kit (MPXCAL-K25). These kits must measure precisely 48 analytes including sCD40L, EGF, Eotaxin, IL-6, TNFα, VEGF-A, and others, with standardized and consistent standard curve ranges across all analytes and must be derived from analytically validated panels compatible with the MAGPIX multiplex reader. The delivery must be FOB Destination to the NIMH facility at 10 Center Drive, Building 10, Room 4A07, Bethesda, MD 20850, with multiple delivery schedules permitted after award, and all submissions must include unit and total pricing, shipping and handling costs, delivery terms, product catalog numbers, and administrative data including a Unique Entity Identifier, Taxpayer Identification Number, business size certification, and active SAM registration. The requirement is not designated as a small business set-aside and is subject to the full suite of applicable Federal Acquisition Regulation provisions effective through FAC 2026-01, primarily FAR 52.212-4 and FAR 52.212-5 for commercial items, along with FAR 52.212-1 and FAR 52.212-3 requiring offeror representations and certifications. Evaluation will be based on best value, weighing price, technical capability, past performance, and delivery schedule, with additional consideration for warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency factors, though specific weightings for each factor are not provided. Responses must be submitted exclusively via the SAM.gov webportal, referencing the solicitation number, and must
General Info
Agency
Contract Value
$27,445.52NAICS
Place of Performance
MDSet-Aside
Awardee
Award Issued Date
Timeline
Submission Closed
Organization & Contact Information
Full Description
For use to analyze oroteins in blood samples toi explore the biomarkers in mood disorders and the effects of novel anti-depressants.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
